drugset / Trial / NCT03080545
Enstilar in Combination With Biologic Agents
NaSingle-groupOpen-labelTreatment
Summary
Patients receiving biologic therapy with 5% or less body surface area will receive Enstilar topical foam for 16 weeks.
Timeline
- Start
- 2017-05-01
- Primary completion
- 2017-10-30
- Completion
- 2017-10-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Calcipotriol | Small molecule | 0.005 % | Topical |
| Subject | betamethasone dipropionate | Small molecule | 0.064 % | Topical |